Wnt pathway markers in low-grade and high-grade gliomas

• Published in: Ideggyógyászati szemle Vol. 74; no. 9-10; pp. 349 - 355
• Main Authors: Nagy, Ádám, Tompa, Márton, Krabóth, Zoltán, Garzuly, Ferenc, Maráczi, Alexandra, Kálmán, Bernadette
• Format: Journal Article
• Language: English
• Published: Hungary 30.09.2021
• Subjects: Brain Neoplasms - genetics; Glioma - genetics; Humans; In Situ Hybridization, Fluorescence; Isocitrate Dehydrogenase - genetics; Isocitrate Dehydrogenase - metabolism; Wnt Signaling Pathway - genetics; lineage; IDH1 mutation; glioma; Wnt pathway; grade
• ISSN: 0019-1442; 2498-6208
• DOI: 10.18071/isz.74.0349

Aberrant activation of the Wnt pathway contributes to differentiation and maintenance of cancer stem cells underlying gliomagenesis. The aim of our research was to determine as to what degrees some Wnt markers are expressed in gliomas of different grades, lineages and molecular subtypes. Nine grade II, 10 grade III and 72 grade IV surgically removed, formalin-fixed paraffin-embedded glioma specimens were included. Mutation status of IDH1 codon 132 was defined by immunohistochemistry and pyrosequencing in all tumors. Grade II and III astrocytic and oligodendroglial tumors were further tested for the expression of p53 and ATRX by immunohistochemistry, and codeletion of 1p19q by fluorescent in situ hybridization. Expression levels of the non-canonical Wnt5a and Fzd2, and the canonical Wnt3a and beta-catenin Wnt pathway markers were determined by immunohistochemistry, and compared between subgroups stratified according to grade, lineage and the presence or absence of IDH1 R132H/C mutations. In the normal brain - grade II-IV glioma comparisons, a gradual increase was observed for the expressions of Wnt5a, Wnt3a, Fzd2 and beta-catenin. In the astroglial and oligodendroglial lineages of grade II and III gliomas, only the Wnt5a expression was significantly higher in the astroglial subgroup. Stratification according to the IDH1 status resulted in a significant increase of the Wnt3 expression in the wild type grade II-IV gliomas. These data extend previous observations and show a correlation of Wnt pathway activity with glioma grade. Further investigations of the Wnt marker expression regulation according to glioma lineage or IDH gene mutational status are in progress by using more exact molecular approaches.